1
|
Moresis A, Restivo L, Bromilow S, Flik G, Rosati G, Scorrano F, Tsoory M, O'Connor EC, Gaburro S, Bannach-Brown A. A minimal metadata set (MNMS) to repurpose nonclinical in vivo data for biomedical research. Lab Anim (NY) 2024; 53:67-79. [PMID: 38438748 PMCID: PMC10912024 DOI: 10.1038/s41684-024-01335-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/21/2023] [Accepted: 01/31/2024] [Indexed: 03/06/2024]
Abstract
Although biomedical research is experiencing a data explosion, the accumulation of vast quantities of data alone does not guarantee a primary objective for science: building upon existing knowledge. Data collected that lack appropriate metadata cannot be fully interrogated or integrated into new research projects, leading to wasted resources and missed opportunities for data repurposing. This issue is particularly acute for research using animals, where concerns regarding data reproducibility and ensuring animal welfare are paramount. Here, to address this problem, we propose a minimal metadata set (MNMS) designed to enable the repurposing of in vivo data. MNMS aligns with an existing validated guideline for reporting in vivo data (ARRIVE 2.0) and contributes to making in vivo data FAIR-compliant. Scenarios where MNMS should be implemented in diverse research environments are presented, highlighting opportunities and challenges for data repurposing at different scales. We conclude with a 'call for action' to key stakeholders in biomedical research to adopt and apply MNMS to accelerate both the advancement of knowledge and the betterment of animal welfare.
Collapse
Affiliation(s)
- Anastasios Moresis
- Roche Pharma Research and Early Development, Data & Analytics, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Basel, Switzerland
| | - Leonardo Restivo
- Neuro-Behavioral Analysis Unit, Faculty of Biology & Medicine, University of Lausanne, Lausanne, Switzerland
| | - Sophie Bromilow
- Group Legal Department, F. Hoffmann-La Roche Ltd, Basel, Switzerland
| | - Gunnar Flik
- Discovery, Charles River Laboratories, Groningen, the Netherlands
| | | | - Fabrizio Scorrano
- Emerging Technologies, Comparative Medicine, Novartis International AG, Basel, Switzerland
| | - Michael Tsoory
- Behavioral and Physiological Phenotyping Unit, Department of Veterinary Resources, Weizmann Institute of Science, Rehovot, Israel
| | - Eoin C O'Connor
- Roche Pharma Research and Early Development, Neuroscience & Rare Diseases, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Basel, Switzerland.
| | | | - Alexandra Bannach-Brown
- QUEST Center for Responsible Research, Berlin Institute of Health at Charité-Universitätsmedizin Berlin, Berlin, Germany.
| |
Collapse
|
2
|
Chiriboga L, Callis GM, Wang Y, Chlipala E. Guide for collecting and reporting metadata on protocol variables and parameters from slide-based histotechnology assays to enhance reproducibility. J Histotechnol 2022; 45:132-147. [DOI: 10.1080/01478885.2022.2134022] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Affiliation(s)
- Luis Chiriboga
- Department of Pathology, NYU Grossman School of Medicine, New York, NY, USA
- NYULH Center for Biospecimen Research and Development, New York, NY, USA
| | | | - Yongfu Wang
- Stowers Institute for Medical Research, Kansas, MO, USA
| | | |
Collapse
|